2025-12-25 - Analysis Report
Okay, here's a breakdown and analysis of Linde PLC (LIN) based on the provided data.

**1. Return Comparison with S&P 500 (VOO)**

*   **Linde PLC (LIN) Overview:** Linde PLC is a global industrial gases and engineering company.
*   **LIN Cumulative Return:** 60.38%
*   **VOO Cumulative Return:** 100.88%
*   **Divergence:** -40.5% (LIN underperformed VOO)
*   **Relative Divergence:** 11.5 (Indicates LIN's current relative divergence is at the 11.5th percentile of its historical divergence range, meaning it's closer to the lower end of its performance compared to VOO).

**Analysis of Alpha, Beta, CAGR, MDD Table:**

Here's the table for reference:

|            Year |   CAGR |   MDD |   Alpha |   Beta |   Cap(B) |
|-----------------|--------|-------|--------|-------|---------|
|       2015-2017 |   36   |   9.2 |      8 |     0   |     73.1 |
|       2016-2018 |   27   |  69.9 |     12 |     0.2 |     73.8 |
|       2017-2019 |   41   |  69.9 |     19 |     0.4 |    100.7 |
|       2018-2020 |   14   |  78.6 |    -10 |     0.4 |    124.6 |
|       2019-2021 |   63   |  78.6 |     16 |     0.9 |    163.8 |
|       2020-2022 |   37   |  78.6 |     38 |     0.8 |    154.2 |
|       2021-2023 |   43   |  76.7 |     41 |     0.5 |    194.2 |
|       2022-2024 |    6   |  76.7 |    -14 |     0.5 |    197.9 |
|       2023-2025 |  -13   |  79.5 |    -79 |     0.5 |    199.2 |

*   **CAGR (Compound Annual Growth Rate):** Highly variable, ranging from -13% to 63%. Performance has dropped significantly in the 2023-2025 period.
*   **MDD (Maximum Drawdown):** Relatively high MDD, especially from 2018 onwards, indicates periods of significant price decline.
*   **Alpha:** Fluctuates widely. Negative Alpha in 2018-2020, 2022-2024 and especially in 2023-2025 means LIN underperformed relative to its expected return based on its beta.
*   **Beta:** Generally low (around 0.5), suggesting that LIN's price is less volatile than the overall market (S&P 500). The beta of 0 in the 2015-2017 period indicates that the price of the LIN stock did not correlate with the market at all during that period.
*   **Cap(B) (Market Capitalization in Billions):** Shows consistent growth in market capitalization over the years, despite some performance dips.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 421.43
*   **Last Market Data:** Price: 424.9, Previous Close: 425.1, Change: -0.05
*   **5-day SMA:** 420.65
*   **20-day SMA:** 408.33
*   **60-day SMA:** 430.80

**Analysis:**

*   The stock price closed at 421.43, but the last market data shows a slight increase to 424.9 before declining by -0.05 from previous close.
*   The 5-day SMA is above the 20-day SMA, suggesting a short-term upward trend.
*   However, the current price and both the 5-day and 20-day SMAs are below the 60-day SMA, indicating a potential longer-term downward trend or consolidation.

**3. RSI, PPO, and Market Risk Indicator Analysis**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 59.00 (Neutral - neither overbought nor oversold)
*   **PPO (Percentage Price Oscillator):** 0.9068 (Indicates the short-term moving average is slightly above the long-term moving average)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (2 shares - Safe (OverSold Boost) - MRI:0.80) Dividend_1.50 (Cash Ratio: 0% on 2025-12-03)
*   **Recent (20 days) relative divergence change:** 1.7 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** 233.6 (High - suggests significant potential for long-term growth exceeding the S&P 500)

**Analysis:**

*   The MRI suggests a medium investment recommendation, indicating a moderate level of risk.
*   The RSI is neutral, not signaling overbought or oversold conditions.
*   The Hybrid Signal recommends buying, influenced by an "oversold boost" and the dividend yield.
*   The positive change in relative divergence over the past 20 days supports a short-term upward trend.
*   The exceptionally high expected return (233.6%) is noteworthy, but needs to be viewed with caution, as it represents a forecast and might be based on specific assumptions.

**4. Recent News & Significant Events (Yahoo Finance):**

*   **Cramer’s Critique and New Credit Facility:** This suggests potential concerns about Linde's performance, but also positive news about financial flexibility.
*   **Swedbank AB Raises Position:** Indicates institutional confidence in the stock.
*   **Analyst Take:** Important to examine the specific analyst ratings for insights.
*   **Linde Stock Price Prediction:** This article needs to be consulted to understand the reasoning behind the prediction (buy, sell, or hold).
*   **6-Day Winning Spree:** Shows recent positive momentum.
*   **Reassessing Valuation:** Indicates the need to evaluate Linde's true worth.

**Analysis:**

The news headlines present a mixed picture: some point to scrutiny and potential underperformance, while others highlight positive momentum, institutional investment, and analyst interest. It's important to read the full articles to understand the context and potential implications.

**4-2. Analyst Opinions:**

*   **Consensus:** Strong Buy
*   **Mean Rating:** 1.50 (leaning towards Buy)
*   **Number of Opinions:** 24
*   **Target Price (avg/high/low):** 502.71 / 565.00 / 381.00

**Analysis:**

The strong buy consensus and a mean rating of 1.50 suggest a generally positive outlook from analysts. The average target price of $502.71 indicates potential upside from the current price. However, the range of target prices (high of $565 and low of $381) suggests some disagreement among analysts.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|----------|------|-----------|
| 2025-10-31 | 4.11 | 8.62 B$   |
| 2025-08-01 | 3.75 | 8.49 B$   |
| 2025-05-01 | 3.53 | 8.11 B$   |
| 2024-10-31 | 3.24 | 8.36 B$   |
| 2025-10-31 | 3.24 | 8.36 B$   |

**Analysis:**

*   Both EPS (Earnings Per Share) and revenue show a general upward trend over the past few quarters. The EPS jumped significantly in 2025-10-31.
*   This suggests improving profitability and revenue generation.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $8.62B   | 49.17%        |
| 2025-06-30   | $8.49B   | 49.31%        |
| 2025-03-31   | $8.11B   | 48.75%        |
| 2024-12-31   | $8.28B   | 47.84%        |
| 2024-09-30   | $8.36B   | 47.87%        |

**Analysis:**

*   Revenue has been increasing, indicating strong sales performance.
*   Profit margins are consistently high (around 48-49%) and showing a slight upward trend, indicating efficient cost management and pricing strategies.

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $38.62B   | 5.00%  |
| 2025-06-30   | $38.52B   | 4.59%  |
| 2025-03-31   | $38.03B   | 4.40%  |
| 2024-12-31   | $38.09B   | 4.53%  |
| 2024-09-30   | $39.17B   | 3.96%  |

**Analysis:**

*   Equity is relatively stable, indicating a healthy financial position.
*   ROE (Return on Equity) has been improving, which suggests that the company is becoming more efficient at generating profits from its shareholders' equity. The significant increase in ROE during 2025-09-30 is worth noting.

**7. Comprehensive Analysis (Summary)**

*   **Performance:** LIN has underperformed the S&P 500 recently. The CAGR has dropped to -13% for the period 2023-2025. However, recent news suggests some positive momentum, and analyst consensus is strongly positive.
*   **Technical Indicators:** Short-term trend is upward based on SMAs and recent divergence. The MRI suggests medium risk, and the RSI is neutral.
*   **Financials:** Revenue, profit margins, and ROE are generally improving, indicating sound financial health. Earnings Per Share (EPS) is showing positive signs.
*   **Analyst Opinion:** Overwhelmingly positive, with "Strong Buy" consensus and an average price target suggesting upside.
*   **News:** Mixed news flow, with some concerns raised but also positive developments like institutional investment.

**Overall Recommendation:**

Based on the available data, LIN presents a mixed picture. While past performance relative to the S&P 500 has been weak, recent financials, analyst sentiment, and technical indicators suggest a potential for improvement. The very high expected return should be viewed cautiously, but the company's strong financial position and positive analyst outlook are encouraging. The medium risk MRI is also very positive news, but the high MDD figure and news articles discussing potential underperformance should also be considered.

Before making any investment decisions, one should do further research.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.